[1]
2026. ASSESSMENT OF PTEN TUMOR SUPPRESSOR PROTEIN BY IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIAS VERSUS CARCINOMAS OVER A FOUR-YEAR PERIOD. Asian Journal of Medical Research and Health Sciences. 4, 2 (Jun. 2026), 1212–1216. DOI:https://doi.org/10.65605/a-jmrhs.2026.v04.i02.pp1212-1216.